Weak spot discovery could pave way for more effective cancer therapies

Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375'000 patients will die from it each year.

Related Keywords

Connecticut ,United States ,University Of Connecticut ,Bern ,Switzerland ,Howardr Soule ,Anke Augspach ,Mark Rubin ,Danielle Ellis ,Rahul Kanadia ,University Of Connecticut United States ,Neurobiology Department ,Bern Center ,University Of Bern ,Us Prostate Cancer Foundation ,Institute For Systems Genomics ,Department For Biomedical Research ,Department Of Physiology ,Inselspital Bern ,Biomedical Research ,Precision Medicine ,Systems Genomics ,Cancer Foundation ,Igor Tulchinsky Leerom ,Executive Vice President ,Chief Science Officer ,Cancer ,Fell ,Genes ,Genomics ,Laboratory ,Medicine ,Hysiology ,Prostate ,Prostate Cancer ,Research ,Skin ,Skin Cancer ,Humor ,